Managing Migraine at work Is it possible to create a safe and inclusive workplace for managing Migraine at work?Yes, it is. Companies need to be aware that an environment that meets the specific needs of those suffering from invisible diseases can become a facilitator and that it is necessary to apply design criteria that reduce […]
Managing Migraine at work Read More »
Messoud Ashina MD PhD DMsc is Professor of Neurology, Danish Headache Center and Department of Neurology, University of Copenhagen, and has been involved into headache research since 1995. He completed his PhD in headache science focusing on tension-type headaches. Since 2006, he has been working on migraine and, in particular, experimental models of migraine. We had the
Meet the Expert: Messoud Ashina Read More »
The Access to Care event: Spain Undervalued, underdiagnosed and undertreated.These words aptly describe the reality of a disabling neurological disease that affects over five million people in Spain: migraine. This type of primary headache causes recurring bouts of moderate or intense pain that may be accompanied by nausea, vomiting or extreme sensitivity to light, sound
Access to care: Spain Read More »
The Access to care: Czech Republic event. Migraine is one of the most common neurological diseases. Nevertheless, it is underestimated and still underdiagnosed and undertreated throughout Europe. Patients who struggle with this disease are subsequently limited in their personal and professional lives, which has, among other things, a secondary social and economic impact on them.
Access to care: Czech Republic Read More »
MTIS 2022: September is a busy month for #MigraineAdvocacy The past weekend, the EMHA was part of the MTIS event, organized by The Migraine Trust, giving voice to all migraine sufferers around Europe. Watch the Opening Ceremony here: We also asked the visitors to sit on the chairs to raise awareness on the time to
GetImpatientForMigraine campaign is based on the insight that migraine sufferers have to wait 8 years for an effective diagnosis and treatment. The EMHA (European Migraine and Headache Alliance), with the support of Motore Sanità , launched the “Access to Migraine Care Survey” on 16 March 2022 in Rome to support migraine sufferers, as part of the
#GetImpatientForMigraine : Progetto Emicrania 2022 Read More »
EMHA is a full member of EPF since 2011. As the European Patient’s Forum states, members are the backbone of their work. Every single member has contributed and continues to contribute to making EPF the leading voice of patient organisations in Europe. Learn more on all of our partners About EPF The European Patients’ Forum (EPF) is
XPatient Barcelona Congress 2021 With the participation of EMHA. The XPatient Barcelona Congress is one of the main actions promoted by the XPA Barcelona (Patient Experience) – a community of practice that brings together institutions from the hospital, technology, research and administration fields – to transform the care model so that it places the patient
XPatient Barcelona Congress 2021 Read More »
Migraine in the EU: EMHA’s ‘Access to Care’ survey reveals shocking hurdles for patients to overcome and disparities in the EU. Presented at the Migraine in the EU: Lifting the barriers to treatment webinar. 29 September 2021, Brussels, Belgium. The European Migraine & Headache Alliance (EMHA) organised a webinar “Migraine in the EU: Lifting the
Migraine in the EU: Lifting the barriers to treatment Read More »
EMHA launches the first Migraine Friendly Workplace Stamp. This new initiative is designed to reduce the impact of migraine in the workplaceand recognizes companies that undertake EMHA training as well as making actionablechange in the workplace. Migraine affects over 41 million adults in Europe (prevalence 14%)1 and as migraine peaksduring individuals’ most productive years of
Migraine Friendly Workplace Stamp at work: The stamp that changes it all Read More »
